New Study Confirms Yaz Birth Control Blood Clot Risks

Tweet

November 9, 2011 – This week, a study published by the Canadian Medical Association has confirmed prior research indicating that the side effects of Yaz and Yasmin birth control pills significantly increase the risk for potentially deadly blood clots over other forms of birth control. This is at least the third study completed over the past month to find an increased risk of blood clots from Bayer’s flagship contraceptives.

Yaz Lawsuit Update 5/2/12: For the third time this year, deadlines for lawsuits over side effects caused by Bayer’s controversial birth control pills Yaz and Yasmin have been extended another 90 days. The move, which was ordered by Chief Judge David R. Herndon of the U.S. District Court for the Southern District of Illinois, allows settlement negotiations to continue between Bayer and plaintiff lawyers for the next three months. Click here to learn more.

Free Yaz Blood Clot Lawsuit Evaluation: If you or a loved one has suffered from a blood clot after taking Yaz, Yasmin, Ocella, or any other birth control product containing drospirenone, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and we can help.

What’s the problem?

The study involved a cohort of more than 300,000 Israeli women, and found that drospirenone-containing birth control products increased the risk of venous thromboembolism by as much as 65% over women taking levonorgestrel and other so-called ‘second generation’ oral contraceptives.

The new study is just the latest to call the safety of Yaz and Yasmin into question, and to declare that these products are likely to be far more dangerous than other forms of birth control. A number of other studies have arrived at similar conclusions.

On October 31st, the U.S. Food & Drug Administration (FDA) released a drug safety report which found that Yaz and Yasmin increased the blood clot risk by up to 75% compared with older birth control products.

Another study published in the British Medical Journal (BMJ) found that women who take drospirenone-containing birth control pills may face twice the risk of developing blood clots compared to women who take levonorgestrel.

Taken cumulatively, the results of these studies appear to support complaints raised in hundreds of Yaz and Yasmin lawsuits filed around the country on behalf of women who allegedly experienced serious and sometimes fatal blood clots after taking the drugs. The lawsuits claim that Bayer failed to adequately warn the public about the risk of serious side effects, placing their desire for profits above patient safety.

An independent advisory committee is set to convene next month to analyze the safety and efficacy of Yaz and Yasmin.

Drospirenone was initially introduced into the market as Yasmin by Berlex Laboratories. After the company was acquired by Bayer Healthcare, an updated version of the drug was released as Yaz. Bayer then introduced a third version, Beyaz, which includes a folate supplement. Generic versions of these drugs are now available from other manufacturers and include:

• Ocella (Barr Laboratories, Inc.)
• Gianvi (Teva Pharmaceuticals)
• Loryna (Sandoz, Inc.)
• Safyral (Bayer Healthcare Pharmaceuticals, Inc.)
• Syeda (Sandoz, Inc.)
• Zarah (Watson Pharmaceuticals)

 

Do You Have a Yaz Lawsuit?

The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Yaz lawsuits. We are handling individual litigation nationwide and currently accepting new blood clot cases in all 50 states.

Free Yaz Lawsuit Evaluation: If you or a loved one has suffered from a blood clot after taking Yaz, Yasmin, Ocella, or any other birth control product containing drospirenone, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and we can help.